Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gemphire Therapeutics
Biotech
NeuroBo backs onto Nasdaq via merger with Gemphire
The move comes as NeuroBo gears up to start a phase 3 trial of nerve growth factor therapy NB-01 in patients with diabetic neuropathic pain.
Nick Paul Taylor
Jul 26, 2019 9:03am
Curis moves up COO as CEO Fattaey departs—Chutes & Ladders
Sep 28, 2018 10:00am
Gemphire cuts 33% of staff, including CFO, CMO
Sep 25, 2018 10:10am
Gemphire pulls the plug on fatty liver disease trial
Aug 10, 2018 10:30am
